Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer
Clinical trial NCT01623102 · UNKNOWN
Trial details
- NCT number
- NCT01623102
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2014-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.